|
Real-time Estimate
Tradegate
09:37:24 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 97.32 EUR | +2.88% |
|
+18.55% | +6.35% |
| 04:16am | BioNTech, neoantigens by proxy |  |
| 08-20 | European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 73.96B | |||||
| 64.66B | |||||
| 27.32B | - | ||||
| 27.86B | - | ||||
| 25.97B |
- Stock Market
- Stocks
- BNTX Stock
- 22UA Stock
- Charts BioNTech SE
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
